- Cognoa launches a pivotal study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder (ASD).- The results of this pivotal study will be the basis for the submission to the FDA in 2020. - The Cognoa digital diagnostic aid has the potential to become the first cleared medical device to help diagnose autism intended to be used by pediatricians and primary care physicians.Cognoa, a Palo Alto, CA-based pediatric behavioral health company developing digital medicines,
Read More
The Innovation Studio at Children’s Hospital Los Angeles Unveils 5 Winners for Digital Health Lab Demo Day
- The Innovation Studio at Children's Hospital Los Angeles (CHLA) announced the winners of its first-ever Digital Health Lab Demo Day. - Winning VR, AR, and gaming innovations will receive $20,000 each in seed grants and be piloted at Children’s Hospital Los Angeles.The Innovation Studio at Children's Hospital Los Angeles (CHLA) announced the winners of its first-ever Digital Health Lab Demo Day, the culmination of a six-month venture to develop, incubate and implement virtual reality (VR),
Read More
Cognoa, EVERSANA Partner to Advance the Commercialization Standard for Prescription Digital Medicines
- Cognoa and EVERSANA form a partnership that will enable prescription, dispensation, and reimbursement of Cognoa’s behavioral health products.
- Cognoa is developing digital medicine solutions to change the standard of care in pediatric behavioral health to improve the lifelong outcomes for children.
- Cognoa selected EVERSANA, a fully integrated and independent commercial services platform, to develop and manage a go-to-market strategy that ensures comprehensive market
Read More
MyHealthTeams Lands $9.44M to Expand Social Networks for Chronic Condition Communities
MyHealthTeams Co-founders Eric Peacock and Mary Ray
MyHealthTeams, a San Francisco, CA-based creator of the largest and fastest-growing social networks for people facing chronic health conditions raised $9.44 million in a Series B financing round led by strategic investor UCB, a global biopharmaceutical company. This financing brings total investment in MyHealthTeams to $26.84M, building on the company's Seed and Series A1, A2 and A3 rounds. Existing investors including Adams Street Partners,
Read More
What Is The Upside of Establishing Extended Reality As A Medical Device?
Eran Orr, Founder of XRHealth
XR stands for extended reality. Basically, it's an umbrella term covering the VR (virtual reality), AR (augmented reality), and MR (mixed reality) technologies. All three are already involved or will be involved in healthcare. In the very near future, you will be able to “swipe” between all three within an application. Different combinations of the technologies will be used to provide specific health benefits, eventually all within a single platform.
It is
Read More
CentralReach Acquires Applied Behavior Analysis Therapy Software Pathfinder Health Innovations
CentralReach, a provider of EHR and practice management solutions that enable Applied Behavior Analysis (ABA) for therapy has acquired Pathfinder Health Innovations (PHI), a practice management and data collection software solution designed for small to medium-sized (SMB) businesses. The acquisition increases CentralReach’s market share and is expected to provide SMB organizations with a quick-start and easy-to-use solution to gain immediate operational efficiencies.Founded in 2010, Pathfinder
Read More
Cognoa Awarded FDA Breakthrough Designations for Diagnostic and Digital Therapeutic Devices for Autism
Cognoa, a digital health company focused on behavioral health for children, today announced FDA Breakthrough designations for it's first diagnostic and therapeutic devices to identify and treat autism. This is the foundation for its AI-based digital precision health to support the developmental and behavioral health of children, combining diagnostics and therapeutics into one platform. This signifies a big step in the company’s expansion into therapeutics.FDA Breakthrough Devices Program
Read More
Cognoa Lands $11.6M for Machine Learning App to Advance Diagnosis of Autism
Cognoa, a Palo Alto, CA-based digital health startup has raised $11.6 million in funding led by existing investor Morningside to advance earlier diagnosis of development delays in children. The company plans to utilize the funding to advance Cognoa's machine-learning-based technology; support additional clinical validation and the U.S. Food and Drug Administration (FDA) submissions and approvals process; and expand commercialization with employers, payers and clinicians. Cognoa has raised a
Read More
